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To the Editor: The development of gut microbiota in the early years of life is essential for immune function and protection against pathogens in humans. [1, 2] Stool sample is often the first choice for analysis of the gut microbiota. The dominant five phyla observed in stool samples have been Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and Fusobacteria, ranked in the order of abundance. However, it might be difficult to obtain the fresh stool sample from infants and young children, especially when they are diseased. In this study, we aimed to evaluate if the rectal swab sample collected from children with hand, foot, and mouth disease (HFMD) can be an alternative for microbiome study using 16S rRNA gene sequencing technology. Fifty swabs were collected from 42 patients. Eight patients also had paired swabs collected in acute and convalescent phases (sampling interval: >7 days between the two samples). Rectal swab was collected in a sterile flask container by perianal stimulation. To minimize the possible effect of sampling and sequencing, three parallel swabs were obtained from each patient and were mixed for DNA extraction. Samples were transferred to the laboratory within 30 min and stored at −80°C.
Genome DNAs were extracted using the Qiagen Stool Mini Kit according to manufacturer's instructions (Hilden, Germany) and diluted to 1 ng/µl using sterile water. The V3-V5 regions were amplified using the specific primers with the barcode, sequenced, and analyzed to define composition of the bacterial community. Sequencing libraries were generated using TruSeq ® DNA PCR-Free Sample Preparation Kit (Illumina, USA) and index codes were added. The library was sequenced on an Illumina HiSeq 2500 platform and 250 bp paired-end reads were generated. Sequences with more than 97% similarity were assigned to the same operational taxonomic units (OTUs). Representative sequence for each OTU was screened for further annotation. Abundance of OTUs was normalized using a standard sequence number corresponding to the sample with the least sequences. Figure 1 shows OTUs cluster and species annotation, sequence numbers classified into different level taxa and comparison of bacterial community composition at the phylum. A total of 3,904,495 tags were generated and clustered into 14,438 OTUs. Of them, 97.3% of the tags were classified into genus-level taxa and 48.0% into species-level taxa [ Figure 1b ]. For each sample, 78,090 tags were generated. Of them, 77,011 taxon tags were clustered into an average of 289 OTUs [ Figure 1a ]. Further, all (100%) of the OTUs could be classified and the average unique tags identified was 1079.
At the phylum level, Firmicutes (mean relative abundance, 58.6%), Bacteroidetes (29.2%), Proteobacteria (6.1%), Actinobacteria (4.2%), and Fusobacteria (0.9%) comprised the vast majority (99.0%) of gut microbiota in the study participants [ Figure 1c ]. At family level, the gut microbiota was generally dominated by Clostridiales family XI Incertae sedis (mean relative abundance 21.8%, with representative genus Ezakiella and Finegoldia), Enterococcaceae (16.6%, representative genus Enterococcus), Prevotellaceae (15.2%, representative genus Prevotella), Bacteroidaceae (6.8%, representative genus Bacteroides), and Enterobacteriaceae (3.8%, representative genus Escherichia/Shigella).
Understanding the link between the intestinal microbiota and health has the potential to improve patient care in the context of infection prevention. [1, 2] Optimizing study feasibility without altering results is critical for research on the gut microbiota in both out-and inpatients. The ongoing project "Impact of gut microbiota on severity of HFMD in children" provided us a unique opportunity to evaluate whether the rectal swabbing from child patients can be an alternative for microbiome study using 16S rRNA gene sequencing technology.
Feces have been widely used for the analysis of intestinal microbiome. Rectal swabbing is a relatively simple means to collect fecal sample among patients hospitalized or at home. It requires no special preparation and can be transported easily from bedside to laboratory. For children and pediatric patients, rectal swabs are more convenient to be collected by parents or nurses. Bassis et al. [3] recently performed the comparison of stool versus rectal swab samples for bacterial community profiles using 16S rRNA gene sequencing in eight adult patients and found that the stool and rectal swab microbiotas from the same participant were highly similar. Kuang et al. [4] used stool samples to study gut microbiota in 29 healthy Chinese infants and obtained a total of 6529 OTUs, with an average of 225 OTUs per sample. The dominant four phyla (Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria) identified comprised over 99% of bacterial community. Using stool samples, Qi et al. [5] recently compared gut microbiota between Chinese children with type 1 diabetes and healthy children (n = 15 for each group). The average OTUs obtained was 132.60 ± 32.29 for controls and 121.53 ± 36.06 for patients. There are certain limitations in this study. First, the number of patients included was limited. Second, parallel stool sample was not available. Third, no sample was obtained from healthy children. In our study, however, we found that both number of (average) OTUs and composition of bacterial communities identified in rectal swabs were rather similar to those reported in stool and rectal swab samples. Our preliminary result suggests that rectal swabs are an acceptable and practical proxy for the collection of fecal specimens for analysis of the intestinal microbiome in children. Further studies in which a large number of participants with parallel stool and rectal swabs are needed to confirm the finding.
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